A Blood Clotting Test for People Having Surgery for a Glial Tumor
Original title: Usefulness of Thromboelastography as a Predictor of Prognosis in Patients Undergoing Surgery for Glial Tumors and of the Risk of Postoperative Thromboembolic Disease (GliTEM)
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is a study in people, and no phase is listed for it.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study asks if a blood test can show who may get blood clots after brain tumor surgery.
Who this trial is for. This study is for people having surgery for a glial tumor, a type of brain tumor. It uses a blood test that shows how the blood forms clots.
Where it stands. The study is looking at two things. One is whether people get blood clots after surgery. The other is how long people live. The team wants to see if the blood test results are linked to either one. The study has not reported results yet.
What this means, and what it doesn't
What it could mean: If the test works as hoped, doctors might one day use it to spot who needs extra care to prevent clots. The team also hopes it could help them plan cancer treatment. If you are having surgery for a glial tumor, you could ask your care team if this study fits you.
What it doesn't mean: This study is a test, not a proven treatment. It has not shown that the blood test can predict anything yet. Taking part does not promise any benefit to you. It is not a cure for brain tumors.
Source: ClinicalTrials.gov, September 10, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.